{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:06:53Z","timestamp":1783940813961,"version":"3.55.0"},"reference-count":43,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Sphingosine-1-phosphate (S1P) is a versatile immunomodulatory lipid mediator that affects both immune and cardiovascular health. S1P has been linked to thyroid health, for example, by affecting inflammatory reactions found in Graves\u2019 disease. In our study, we explored associations of S1P with thyroid markers obtained from laboratory tests (thyrotropin (TSH), free triiodothyronine (fT3), and free thyroxine (fT4)) and ultrasound examination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We quantified S1P by LC\u2013MS\/MS in participants from the population-based \u2018Study of Health in Pomerania\u2019 conducted in Northeast Germany. Serum levels of TSH, fT3, and fT4 were measured using chemiluminescent immunoassays. Thyroid volume, thyroid nodules, and echogenic patterns were assessed by ultrasonography. Cross-sectional associations between serum S1P and thyroid biomarkers were evaluated using multivariable linear regression models adjusted for confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The total study population consisted of 4,034 participants (51.6% women aged 20\u201384 years). A 1 \u03bcmol\/L higher S1P level was associated with a 0.17 mIU\/L lower TSH level (95% confidence interval (CI): \u22120.32; \u22120.04) and a 0.52 pmol\/L (0.42; 0.63) higher fT3 level. These associations persisted after excluding individuals with high or low serum TSH levels and those taking thyroid medication. S1P levels were not significantly associated with serum fT4 levels. Higher S1P levels were associated with a larger thyroid volume, the presence of thyroid nodules, and a hypoechogenic thyroid pattern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Circulating S1P is inversely associated with TSH and positively associated with fT3, suggesting a potential modulatory role of S1P in thyroid function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-26-0034","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:50:15Z","timestamp":1782147015000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":0,"title":["Associations of sphingosine-1-phosphate with thyroid function and structure: a cross-sectional population-based study"],"prefix":"10.1530","volume":"15","author":[{"given":"Lisa","family":"B\u00e4hr","sequence":"first","affiliation":[{"name":"Department of Internal Medicine B \u2013 Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, University Medicine Greifswald 1 , ,","place":["Greifswald, Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gross","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B \u2013 Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, University Medicine Greifswald 1 , ,","place":["Greifswald, Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]},{"name":"Institute for Community Medicine\/SHIP Clinical-Epidemiological Research, University Medicine Greifswald 3 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard H","family":"Rauch","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, University Medicine Oldenburg, Carl von Ossietzky University Oldenburg 4 , ,","place":["Oldenburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Friedrich","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]},{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald 5 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edzard","family":"Schwedhelm","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]},{"name":"Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf 6 , ,","place":["Hamburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Daum","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf 6 , ,","place":["Hamburg, Germany"]},{"name":"Department of Vascular Medicine, University Heart and Vascular Center Hamburg-Eppendorf 7 , ,","place":["Hamburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Templin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B \u2013 Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, University Medicine Greifswald 1 , ,","place":["Greifswald, Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello RP","family":"Markus","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B \u2013 Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, University Medicine Greifswald 1 , ,","place":["Greifswald, Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-399X","authenticated-orcid":true,"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[{"name":"Institute for Community Medicine\/SHIP Clinical-Epidemiological Research, University Medicine Greifswald 3 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bahls","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B \u2013 Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, University Medicine Greifswald 1 , ,","place":["Greifswald, Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-7353","authenticated-orcid":true,"given":"Till","family":"Ittermann","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North 2 , ,","place":["Greifswald, Germany"]},{"name":"Institute for Community Medicine\/SHIP Clinical-Epidemiological Research, University Medicine Greifswald 3 , ,","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026071306315308600_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1139221","article-title":"Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate","volume":"316","author":"Pappu","year":"2007","journal-title":"Science"},{"key":"2026071306315308600_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.54.2.265","article-title":"International union of pharmacology. XXXIV. Lysophospholipid receptor nomenclature","volume":"54","author":"Chun","year":"2002","journal-title":"Pharmacol Rev"},{"key":"2026071306315308600_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","article-title":"Vascular endothelium as a contributor of plasma sphingosine 1-phosphate","volume":"102","author":"Venkataraman","year":"2008","journal-title":"Circ Res"},{"key":"2026071306315308600_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3520809","article-title":"Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions","volume":"352","author":"Murata","year":"2000","journal-title":"Biochem J"},{"key":"2026071306315308600_bib5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G protein\u2013coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation","volume":"106","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"2026071306315308600_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.117.09088","article-title":"S1PR1 (sphingosine-1-phosphate receptor 1) signaling regulates blood flow and pressure","volume":"70","author":"Cantalupo","year":"2017","journal-title":"Hypertension"},{"key":"2026071306315308600_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/biom13050818","article-title":"Sphingosine-1-phosphate signaling in cardiovascular diseases","volume":"13","author":"Wang","year":"2023","journal-title":"Biomolecules"},{"key":"2026071306315308600_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10408363.2013.813013","article-title":"Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy","volume":"50","author":"Egom","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2026071306315308600_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ni.3619","article-title":"Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-\u03b3 response","volume":"18","author":"Fang","year":"2017","journal-title":"Nat Immunol"},{"key":"2026071306315308600_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/cvr\/cvad183","article-title":"Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways","volume":"120","author":"Velagapudi","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2026071306315308600_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2022.03.020","article-title":"Sphingosine-1-phosphate and vascular disease in the general population","volume":"350","author":"Rotheudt","year":"2022","journal-title":"Atherosclerosis"},{"key":"2026071306315308600_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/antiox12010143","article-title":"Sphingolipids and atherosclerosis: the dual role of ceramide and sphingosine-1-phosphate","volume":"12","author":"Piccoli","year":"2023","journal-title":"Antioxidants"},{"key":"2026071306315308600_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168302","article-title":"Serum-Sphingosine-1-Phosphate concentrations are inversely associated with atherosclerotic diseases in humans","volume":"11","author":"Soltau","year":"2016","journal-title":"PLoS One"},{"key":"2026071306315308600_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pbiomolbio.2010.01.001","article-title":"Cardioprotection in ischemia\/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling","volume":"103","author":"Egom","year":"2010","journal-title":"Prog Biophys Mol Biol"},{"key":"2026071306315308600_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.coph.2008.11.002","article-title":"Targeting sphingosine-1-phosphate signalling for cardioprotection","volume":"9","author":"Kennedy","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"2026071306315308600_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003393","article-title":"Sphingosine-1-phosphate receptor 1 regulates cardiac function by modulating Ca2+ sensitivity and Na+\/H+ exchange and mediates protection by ischemic preconditioning","volume":"5","author":"Keul","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026071306315308600_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jbior.2015.09.006","article-title":"Sphingosine-1-phosphate and estrogen signaling in breast cancer","volume":"60","author":"Maczis","year":"2016","journal-title":"Adv Bio Regul"},{"key":"2026071306315308600_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc2875","article-title":"Sphingosine 1-phosphate and cancer","volume":"10","author":"Pyne","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2026071306315308600_bib19","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2353\/ajpath.2010.100220","article-title":"High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1\/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients","volume":"177","author":"Watson","year":"2010","journal-title":"Am J Pathol"},{"key":"2026071306315308600_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/BJ20060299","article-title":"Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells","volume":"398","author":"Balthasar","year":"2006","journal-title":"Biochem J"},{"key":"2026071306315308600_bib21","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.3390\/cancers14235838","article-title":"Suppression of calcium entry modulates the expression of TR\u03b21 and Runx2 in thyroid cancer cells, two transcription factors that regulate invasion, proliferation and thyroid-specific protein levels","volume":"14","author":"Asghar","year":"2022","journal-title":"Cancers"},{"key":"2026071306315308600_bib22","first-page":"5007","article-title":"SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P\/S1PR3\/Notch signaling pathway","volume":"15","author":"Zhao","year":"2018","journal-title":"Exp Ther Med"},{"key":"2026071306315308600_bib23","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1093\/ije\/dyac034","article-title":"Cohort profile update: the study of health in pomerania (SHIP)","volume":"51","author":"Volzke","year":"2022","journal-title":"Int J Epidemiol"},{"key":"2026071306315308600_bib24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1055\/s-2008-1067777","article-title":"Ultraschalldiagnostik der schilddr\u00fcse","volume":"113","author":"Gutekunst","year":"1988","journal-title":"Dtsch Med Wochenschr"},{"key":"2026071306315308600_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-14-0898","article-title":"Shift of the TSH reference range with improved iodine supply in Northeast Germany","volume":"172","author":"Ittermann","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026071306315308600_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2017.01.029","article-title":"Reference intervals for serum sphingosine-1-phosphate in the population-based study of health in pomerania","volume":"468","author":"Moritz","year":"2017","journal-title":"Clin Chim Acta"},{"key":"2026071306315308600_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00038-012-0362-0","article-title":"Linear, nonlinear or categorical: how to treat complex associations in regression analyses? Polynomial transformations and fractional polynomials","volume":"58","author":"Schmidt","year":"2013","journal-title":"Int J Publ Health"},{"key":"2026071306315308600_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/9780470770771","volume-title":"Multivariable Model-Building: A Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables","author":"Royston","year":"2008"},{"key":"2026071306315308600_bib29","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.2147\/JIR.S302117","article-title":"Increased Sphingosine-1-phosphate serum concentrations in subjects with periodontitis: a matter of inflammation","volume":"14","author":"Moritz","year":"2021","journal-title":"J Inflamm Res"},{"key":"2026071306315308600_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00011-017-1037-3","article-title":"Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves\u2019 orbitopathy","volume":"66","author":"Seo","year":"2017","journal-title":"Inflamm Res"},{"key":"2026071306315308600_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209050","article-title":"Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2","volume":"13","author":"Matsushima-Nishiwaki","year":"2018","journal-title":"PLoS One"},{"key":"2026071306315308600_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115838","article-title":"The role of SphK\/S1P\/S1PR signaling pathway in bone metabolism","volume":"169","author":"Xu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026071306315308600_bib33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1096\/fj.06-7420com","article-title":"Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration","volume":"21","author":"Novgorodov","year":"2007","journal-title":"FASEB J"},{"key":"2026071306315308600_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81415","article-title":"Computational model of the full-length TSH receptor","volume":"11","author":"Mezei","year":"2022","journal-title":"eLife"},{"key":"2026071306315308600_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5603\/EP.a2020.0052","article-title":"Thyroid gland dysfunction and its effect on the cardiovascular system: a comprehensive review of the literature","volume":"71","author":"Ahmadi","year":"2020","journal-title":"Endokrynol Pol"},{"key":"2026071306315308600_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vph.2009.09.004","article-title":"Thyroid hormone and atherosclerosis","volume":"52","author":"Ichiki","year":"2010","journal-title":"Vasc Pharmacol"},{"key":"2026071306315308600_bib37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5551\/jat.32755","article-title":"Thyroid hormone and vascular remodeling","volume":"23","author":"Ichiki","year":"2016","journal-title":"J Atherosclerosis Thromb"},{"key":"2026071306315308600_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","article-title":"Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study","volume":"132","author":"Hak","year":"2000","journal-title":"Ann Intern Med"},{"key":"2026071306315308600_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3803\/EnM.2022.1463","article-title":"Thyroid function across the lifespan: do age-related changes matter?","volume":"37","author":"Walsh","year":"2022","journal-title":"Endocrinol Metab"},{"key":"2026071306315308600_bib40","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7326\/0003-4819-87-6-760","article-title":"Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications","volume":"87","author":"Schimmel","year":"1977","journal-title":"Ann Intern Med"},{"key":"2026071306315308600_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1573403X15666191008111238","article-title":"The role of thyroid diseases and their medications in cardiovascular disorders: a review of the literature","volume":"16","author":"Omidi","year":"2020","journal-title":"Curr Cardiol Rev"},{"key":"2026071306315308600_bib42","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jcem.83.8.5000","article-title":"Reentrant atrioventricular nodal tachycardia induced by levothyroxine","volume":"83","author":"Biondi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2026071306315308600_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1170884","article-title":"Sphingolipids in thyroid eye disease","volume":"14","author":"Gulbins","year":"2023","journal-title":"Front Endocrinol"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/aop\/ETJ-26-0034\/ETJ-26-0034.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/aop\/ETJ-26-0034\/ETJ-26-0034.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-26-0034\/519738\/etj-26-0034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-26-0034\/519738\/etj-26-0034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:32:02Z","timestamp":1783938722000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/4\/ETJ260034\/77533\/Associations-of-sphingosine-1-phosphate-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-26-0034","relation":{},"ISSN":["2235-0802"],"issn-type":[{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"ETJ260034"}}